P LIPTON AND SONS LIMITED

Financial Health Assessment: P LIPTON AND SONS LIMITED

1. Financial Health Score: D+ The patient is suffering from chronic equity erosion and acute cash flow anemia. While the business is currently still standing (active and filing on time), its underlying vital signs are deteriorating. A deeply negative profit and loss reserve indicates long-term internal bleeding of retained earnings, and a sudden, massive spike in trade creditors suggests the business is gasping for cash flow, relying on unpaid supplier bills to keep the heart pumping.

2. Key Vital Signs * Net Assets (The Patient's Weight): Dropping. Net assets have fallen from £42,162 in 2019 to just £19,796 in 2025. This steady weight loss indicates the business is consuming its own reserves to survive. * P&L Reserve (Muscle Mass): Emaciated. The accumulated profit and loss reserve stands at a negative (£85,204). This means that over its lifetime, the company has incurred substantial losses that have entirely consumed its £105,000 share capital buffer, leaving it structurally very weak. * Current Ratio (Blood Oxygenation): Superficially Adequate, Fundamentally Flawed. At 1.27 (£243,314 / £191,806), the current ratio looks acceptable on the surface. However, £231,944 (over 95%) of the current assets are tied up in inventory. Inventory is the "cholesterol" of current assets—it takes time to convert into cash. Real cash liquidity is dangerously low. * Trade Creditors (Blood Pressure): Dangerously High. Trade creditors have spiked from £24,795 in 2024 to £87,610 in 2025—a 253% increase. This is a classic symptom of a business delaying payments to suppliers because it lacks the cash flow to pay its bills on time. * Debtors (Circulation): Slowing. Trade debtors have dropped significantly from £15,550 to £2,595, which could mean the business is collecting cash faster, but combined with the spike in creditors, it more likely indicates a slowdown in new sales volume.

3. Diagnosis: Chronic Equity Erosion with Working Capital Constriction The financial data reveals a business that is struggling to generate a profit. The company has been operating with a negative P&L reserve for several years, meaning it is clinically "underwater" in terms of historical retained earnings, surviving only on the life support of its original share capital.

The most alarming symptom in the latest period (year ending March 2025) is the massive shift in the balance sheet. Inventory has increased slightly, but trade creditors have nearly tripled. This indicates a severe "working capital constriction"—the business is stocking up on goods (or holding unsold stock) but is unable to convert those goods into cash quickly enough to pay its suppliers. The suppliers are effectively financing the company's operations. Furthermore, the tangible fixed assets (property, plant, and equipment) are almost entirely fully depreciated (£14,388 net book value remaining from £204,075 cost), meaning the business's physical operating equipment is aging and will soon require capital replacement.

4. Recommendations: Prescribed Treatment Plan * Clear the Arteries (Inventory Liquidation): With £231,944 tied up in stock, the business must aggressively move slow-moving or obsolete inventory. Consider discounting older stock to convert it into much-needed cash, even if it means accepting a lower margin. * Stabilize Blood Pressure (Creditor Management): The tripling of trade creditors is a red flag for supplier relationships, which could result in restricted credit terms or legal action. Open dialogue with key suppliers to negotiate extended payment terms or structured payment plans before the situation reaches a crisis point. * Stop the Bleeding (Profitability Review): The P&L reserve has worsened by £4,860 this year. A thorough review of operating costs and pricing strategy is required to ensure the business is generating a gross margin sufficient to cover overheads. * Capex Health Check: With fixed assets almost entirely depreciated, assess the remaining useful life of current plant and machinery. Do not take on new debt to finance equipment until the working capital position is stabilized.